The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

Zaheer-Ud-Din Babar; Charon Lessing; Cécile Mace; Karen Bissell

首页> 外文期刊>PharmacoEconomics >The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

【24h】

The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

机译：52种低收入和中收入国家/地区三种哮喘药物的供应，定价和可负担性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Almost 300 million people suffer from asthma, yet many in low- and middle-income countries have difficulty accessing essential asthma medicines. Availability, price and affordability of medicines are likely to affect access. Very few studies have included asthma medicines, particularly inhaled corticosteroids, in these countries. Reflections about international reference prices (IRPs) are generally absent from pricing studies, yet some IRPs may be masking the extent of access problems.

机译：背景知识将近3亿人患有哮喘病，但中低收入国家/地区的许多人难以获得基本的哮喘药物。药品的可用性，价格和可负担性可能会影响药品的获取。在这些国家中，很少有研究包括哮喘药物，尤其是吸入性糖皮质激素。定价研究通常没有对国际参考价格（IRP）的思考，但是一些IRP可能掩盖了获取问题的程度。

著录项

来源
《PharmacoEconomics》 |2013年第11期|1063-1082|共20页
作者
Zaheer-Ud-Din Babar; Charon Lessing; Cécile Mace; Karen Bissell;
展开▼
作者单位

School of Pharmacy The University of Auckland">(1);

School of Pharmacy The University of Auckland">(1);

International Union Against Tuberculosis and Lung Disease">(2);

International Union Against Tuberculosis and Lung Disease">(2);

School of Population Health The University of Auckland">(3);

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries [J] . BabarZ.-U.-D., LessingC., MaceC., PharmacoEconomics . 2013,第11期

机译：52个中低收入国家/地区中三种基本哮喘药物的可获得性，定价和可负担性
2. Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature [J] . Phyllis Ocran Mattila, Rabbiya Ahmad, Syed Shahzad Hasan, Frontiers in Public Health . 2021,第a期

机译：低收入和中等收入国家的抗癌药物的可用性，负担能力，访问和定价：对文学的系统审查
3. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico [J] . Daniela Moye-Holz, Margaret Ewen, Anahi Dreser, BMC Health Services Research . 2020,第1期

机译：中等收入国家所选必要癌症药物的可用性，价格和可负担性 - 墨西哥的案例
4. HEALTHQUAL International All Country Learning Network (ACLN): A Peer-Driven Knowledge Management Strategy and Community of Practice to Build Capacity for Sustainable National Quality Management Programs in Low- and Middle-Income Countries [C] . Joshua Bardfield, Margaret Palumbo, Richard Birchard, International Conference on Intellectual Capital, Knowledge Management and Organisational Learning . 2013

机译：HealthQual International所有国家学习网络（ACLN）：对低收入和中等收入国家的可持续国家质量管理计划的能力建立能力的同行知识管理战略和惯例
5. The Use of Prototypes to Engage Stakeholders in Low- and Middle-Income Countries During the Early Phases of Design [D] . Coulentianos, Marianna. 2020

机译：在设计的早期阶段，使用原型在低收入中的利益相关者
6. Availability Affordability Access and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature [O] . Phyllis Ocran Mattila, Rabbiya Ahmad, Syed Shahzad Hasan, 2021

机译：低收入和中等收入国家的抗癌药物的可用性可负担性访问和定价：对文学的系统审查
7. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries [O] . Mendis, Shanti, Fukino, Keiko, Cameron, Alexandra, 2007

机译：在六个低收入和中等收入国家中，用于慢性病的某些基本药物的供应和可负担性

The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries

摘要

著录项

相似文献

相关主题

期刊订阅